Citations 1
ELAINE 3: phase 3 study of lasofoxifene plus abemaciclib to treat ER+/HER2-, ESR1 -mutated, metastatic breast cancer
Bachelot, Thomas , Sammons, Sarah , Shen, Sherry , Twelves, Chris, Boruta, Gina, Portman, David, Sammons, Sarah L , Goetz, Matthew P. , Wander, Seth Andrew , Nonneville, Alexandre Tassin de , Gal‐Yam, Einav Nili , Damodaran, Senthil
Future Oncology | April 13, 2025 | Volume: 21 | Issue: 11 | Pages: 1317-1324
